Skip to main content
Watch Insiders
BBIO filings

Corporate insider profile

Neil Kumar Filing Activity

Latest reported as Chief Executive Officer of BridgeBio Pharma, Inc. (BBIO).

Purchase filings
0
Reported companies
1
Net open-market value
-$12,618,049.84
Latest transaction
Jun 5, 2026

Affiliated corporations

Reported company relationships

BBIOLatest reported

BridgeBio Pharma, Inc.

Chief Executive Officer

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Jun 5, 2026BridgeBio Pharma, Inc. (BBIO)Chief Executive OfficerSale80,000$67.67$5,413,288
May 21, 2026BridgeBio Pharma, Inc. (BBIO)Chief Executive OfficerSale26,103$69.44$1,812,522
May 8, 2026BridgeBio Pharma, Inc. (BBIO)Chief Executive OfficerSale80,000$67.40$5,392,240